Decreased Circulating Levels of Tumor Necrosis Factor-alpha in Postmenopausal Women during Consumption of Soy-Containing Isoflavones

Remember that the latest and greatest class of medications to hit the market are the  “biological agents,” such as the TNF-alpha blockers like Remicade and Enbral.  But I have serous long term concerns with this approach, as TNF-alpha is one of our body’s ways of dealing with cancer cells.  Well, instead of blocking the action of TNF-alpha, how about the novel concept of less of it in the first place?  We already know that lowering insulin levels can lower TNF-alpha levels, but now we see a whopping 66.7% reduction in circulating TNF-alpha levels after 10 weeks with use of a soy drink.  Lets compare.

TNF-alpha blockers:  probably increase risk of cancer, infections, TB, blah, blah, blah.  About $1K/month.  Soy:  protects against high cholesterol, lowers risk of breast and endometrial cancer, protects bone, some people allergic.  About $35/month.  Look on your rheumatologists face:  priceless.

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.